Evidence for Rare Capsular Switching in Streptococcus agalactiae

ABSTRACT The polysaccharide capsule is a major antigenic factor in Streptococcus agalactiae (Lancefield group B streptococcus [GBS]). Previous observations suggest that exchange of capsular loci is likely to occur rather frequently in GBS, even though GBS is not known to be naturally transformable. We sought to identify and characterize putative capsular switching events, by means of a combination of phenotypic and genotypic methods, including pulsed-field gel electrophoretic profiling, multilocus sequence typing, and surface protein and pilus gene profiling. We show that capsular switching by horizontal gene transfer is not as frequent as previously suggested. Serotyping errors may be the main reason behind the overestimation of capsule switching, since phenotypic techniques are prone to errors of interpretation. The identified putative capsular transformants involved the acquisition of the entire capsular locus and were not restricted to the serotype-specific central genes, the previously suggested main mechanism underlying capsular switching. Our data, while questioning the frequency of capsular switching, provide clear evidence for in vivo capsular transformation in S. agalactiae, which may be of critical importance in planning future vaccination strategies against this pathogen.

[1]  W. Schaffner,et al.  Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Alexandre P. Francisco,et al.  Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach , 2009, BMC Bioinformatics.

[3]  M. Ramirez,et al.  A Confidence Interval for the Wallace Coefficient of Concordance and Its Application to Microbial Typing Methods , 2008, PloS one.

[4]  P. Glaser,et al.  Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae , 2008, Proceedings of the National Academy of Sciences.

[5]  F. Kong,et al.  Use of Phenotypic and Molecular Serotype Identification Methods To Characterize Previously Nonserotypeable Group B Streptococci , 2008, Journal of Clinical Microbiology.

[6]  H. Davies,et al.  Genotypic diversity and serotype distribution of group B streptococcus isolated from women before and after delivery. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Ramirez,et al.  Streptococcus agalactiae Serotype Ib as an Agent of Meningitis in Two Adult Nonpregnant Women , 2007, Journal of Clinical Microbiology.

[8]  D. Crook,et al.  Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States , 2007, PLoS pathogens.

[9]  J. Melo-Cristino,et al.  Reevaluating the Serotype II Capsular Locus of Streptococcus agalactiae , 2007, Journal of Clinical Microbiology.

[10]  M. Ramirez,et al.  Analysis of Group B Streptococcal Isolates from Infants and Pregnant Women in Portugal Revealing Two Lineages with Enhanced Invasiveness , 2007, Journal of Clinical Microbiology.

[11]  M. Ramirez,et al.  Nonoutbreak Surveillance of Group A Streptococci Causing Invasive Disease in Portugal Identified Internationally Disseminated Clones among Members of a Genetically Heterogeneous Population , 2007, Journal of Clinical Microbiology.

[12]  I. Margarit,et al.  Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae , 2006, Molecular microbiology.

[13]  J A Carriço,et al.  Illustration of a Common Framework for Relating Multiple Typing Methods by Application to Macrolide-Resistant Streptococcus pyogenes , 2006, Journal of Clinical Microbiology.

[14]  L. Paoletti,et al.  Molecular Characterization of Nontypeable Group B Streptococcus , 2006, Journal of Clinical Microbiology.

[15]  H. Tettelin,et al.  Identification of novel cps locus polymorphisms in nontypable group B Streptococcus. , 2006, Journal of medical microbiology.

[16]  C. Buchrieser,et al.  Genomic diversity and evolution within the species Streptococcus agalactiae. , 2006, Microbes and infection.

[17]  B. Spratt,et al.  Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J A Carriço,et al.  Assessment of Band-Based Similarity Coefficients for Automatic Type and Subtype Classification of Microbial Isolates Analyzed by Pulsed-Field Gel Electrophoresis , 2005, Journal of Clinical Microbiology.

[19]  Jaideep P. Sundaram,et al.  Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Spratt,et al.  Multilocus Sequence Typing of Swedish Invasive Group B Streptococcus Isolates Indicates a Neonatally Associated Genetic Lineage and Capsule Switching , 2005, Journal of Clinical Microbiology.

[21]  M. Weinstein,et al.  The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. , 2005, Vaccine.

[22]  Gustavo Glusman,et al.  Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides , 2005, Infection and Immunity.

[23]  J A Carriço,et al.  Characterization of the Genetic Lineages Responsible for Pneumococcal Invasive Disease in Portugal , 2005, Journal of Clinical Microbiology.

[24]  H. Konradsen Validation of serotyping of Streptococcus pneumoniae in Europe. , 2005, Vaccine.

[25]  David A. Nix,et al.  GATA: a graphic alignment tool for comparative sequence analysis , 2005, BMC Bioinformatics.

[26]  M. Ramírez,et al.  Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. , 2004, Microbial drug resistance.

[27]  H. Davies,et al.  Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. , 2004, The Journal of infectious diseases.

[28]  C. von Hunolstein,et al.  Multiplex PCR Assay for Direct Identification of Group B Streptococcal Alpha-Protein-Like Protein Genes , 2004, Journal of Clinical Microbiology.

[29]  B. Foxman,et al.  Comparison of DNA Dot Blot Hybridization and Lancefield Capillary Precipitin Methods for Group B Streptococcal Capsular Typing , 2004, Journal of Clinical Microbiology.

[30]  E. Bingen,et al.  Molecular characterization of serotype III group B-streptococcus isolates causing neonatal meningitis. , 2003, The Journal of infectious diseases.

[31]  Philippe Glaser,et al.  Multilocus Sequence Typing System for Group B Streptococcus , 2003, Journal of Clinical Microbiology.

[32]  N. Nagano,et al.  High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci. , 2002, Infection and immunity.

[33]  F. Kong,et al.  Serotype Identification of Group B Streptococci by PCR and Sequencing , 2002, Journal of Clinical Microbiology.

[34]  S. Håkansson,et al.  Genotyping of the Capsule Gene Cluster (cps) in Nontypeable Group B Streptococci Reveals Two Majorcps Allelic Variants of Serotypes III and VII , 2000, Journal of Clinical Microbiology.

[35]  S. Iijima,et al.  Molecular Characterization of Type-Specific Capsular Polysaccharide Biosynthesis Genes of Streptococcus agalactiae Type Ia , 1999, Journal of bacteriology.

[36]  A. Tomasz,et al.  Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae. , 1999, Microbial drug resistance.

[37]  E. Adderson,et al.  Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. , 1998, The Journal of infectious diseases.

[38]  A. Tomasz,et al.  Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. , 1998, The Journal of infectious diseases.

[39]  R. Selander,et al.  Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease , 1995, Journal of clinical microbiology.

[40]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[41]  J. Musser,et al.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Kasper,et al.  Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus. , 1983, Biochemistry.

[43]  G. T. Mills,et al.  SIMULTANEOUS PRODUCTION OF TWO CAPSULAR POLYSACCHARIDES BY PNEUMOCOCCUS , 1959, Journal of Experimental Medicine.

[44]  R. Lancefield,et al.  TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES , 1943, The Journal of experimental medicine.